regulation of intracellular protein transport (GO:0033157) | - | 3.8 | 0.004 | AKT1, CASP8, BARD1, TP53, CDH1, PIK3CA, ESR1, BRCA1, TSG101 |
organophosphate catabolic process (GO:0046434) | NEW | 5.03 | 0.002 | ATM, PHB, XRCC3, KRAS, BRCA2, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRIP1, RAD51 |
positive regulation of secretion (GO:0051047) | NEW | 3.85 | 0.02 | ATM, KRAS, ESR1, TP53, CDH1, PIK3CA, AKT1, CHEK2, HMMR |
protein acylation (GO:0043543) | NEW | 4.65 | 0.038 | BRCA2, ESR1, TP53, AKT1, CHEK2, TSG101 |
regulation of protein import into nucleus, translocation (GO:0033158) | NEW | 6.68 | 0.045 | ESR1, TP53, AKT1 |
nucleotide catabolic process (GO:0009166) | NEW | 5.67 | 0.006 | ATM, PHB, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
purine ribonucleoside monophosphate metabolic process (GO:0009167) | NEW | 4.7 | 0.003 | PHB, ATM, XRCC3, BRCA2, AKT1, TP53, ESR1, BRCA1, BRIP1, RAD51 |
nucleoside catabolic process (GO:0009164) | NEW | 6.17 | 0.005 | ATM, PHB, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
ribonucleoside monophosphate metabolic process (GO:0009161) | NEW | 4.62 | 0.005 | PHB, ATM, XRCC3, BRCA2, AKT1, TP53, ESR1, BRCA1, BRIP1, RAD51 |
purine ribonucleoside monophosphate catabolic process (GO:0009169) | NEW | 8.12 | 0.005 | PHB, ATM, BRCA2, XRCC3, TP53, ESR1, BRCA1, BRIP1, RAD51 |
cellular response to stimulus (GO:0051716) | - | 1.97 | 0.001 | ATM, NBN, XRCC3, KRAS, BRCA2, AKT1, CASP8, PALB2, CDH1, BARD1, TP53, PHB, FAM175A, RB1CC1, PIK3CA, ESR1, CHEK2, RAD54L, BRIP1, BRCA1, RAD51 |
double-strand break repair (GO:0006302) | - | 4.73 | 0.0 | ATM, NBN, BRCA2, PALB2, TP53, FAM175A, XRCC3, CHEK2, BRCA1, BRIP1, RAD54L, RAD51 |
signal transduction involved in DNA damage checkpoint (GO:0072422) | - | 5.55 | 0.038 | ATM, CHEK2, ESR1, TP53 |
regulation of apoptotic signaling pathway (GO:2001233) | - | 3.83 | 0.0 | PHB, KRAS, AKT1, CASP8, RAD51, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, HMMR |
MAPK cascade (GO:0000165) | - | 3.91 | 0.0 | ATM, KRAS, AKT1, CASP8, TP53, RB1CC1, PIK3CA, ESR1, BRCA1 |
ribonucleoside triphosphate metabolic process (GO:0009199) | NEW | 4.77 | 0.007 | ATM, PHB, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
regulation of mitosis (GO:0007088) | - | 4.83 | 0.017 | ATM, PPM1D, CDH1, TP53, AKT1, TSG101 |
regulation of DNA repair (GO:0006282) | - | 5.4 | 0.0 | ESR1, TP53, FAM175A, AKT1, BRCA1, RAD51 |
DNA repair (GO:0006281) | - | 3.59 | 0.0 | ATM, NBN, XRCC3, BRCA2, AKT1, PALB2, BARD1, TP53, FAM175A, ESR1, CHEK2, BRCA1, BRIP1, RAD54L, RAD51 |
internal protein amino acid acetylation (GO:0006475) | NEW | 4.99 | 0.004 | BRCA2, ESR1, TP53, AKT1, CHEK2, TSG101 |
regulation of protein kinase activity (GO:0045859) | - | 3.15 | 0.011 | PHB, ATM, KRAS, AKT1, CASP8, TP53, CDH1, RAD51, ESR1, PIK3CA, BRCA1, CHEK2, HMMR |
regulation of cell size (GO:0008361) | - | 5.42 | 0.016 | RB1CC1, KRAS, TP53, AKT1 |
glycerolipid metabolic process (GO:0046486) | - | 3.91 | 0.0 | ATM, KRAS, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1, TSG101 |
somitogenesis (GO:0001756) | - | 5.9 | 0.003 | ATM, BRCA1, BRIP1, PALB2, TP53 |
heterocycle metabolic process (GO:0046483) | - | 1.31 | 0.013 | PHB, ATM, XRCC3, BRCA2, AKT1, PALB2, BARD1, TP53, FAM175A, RB1CC1, KRAS, ESR1, NBN, CHEK2, BRCA1, BRIP1, RAD54L, RAD51 |
positive regulation of phosphorylation (GO:0042327) | - | 2.9 | 0.001 | ATM, NBN, KRAS, AKT1, CASP8, PPM1D, TP53, PHB, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
negative regulation of phosphorylation (GO:0042326) | - | 3.7 | 0.0 | ATM, KRAS, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
response to biotic stimulus (GO:0009607) | - | 3.09 | 0.003 | ATM, KRAS, AKT1, CASP8, PPM1D, RAD51, TP53, CDH1, PIK3CA, ESR1, RAD54L, CHEK2, HMMR |
regulation of DNA replication (GO:0006275) | - | 5.02 | 0.033 | ATM, NBN, BRCA2, AKT1, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2 |
regulation of nuclear division (GO:0051783) | - | 4.67 | 0.005 | ATM, PPM1D, CDH1, TP53, AKT1, CHEK2, TSG101 |
positive regulation of catabolic process (GO:0009896) | - | 3.94 | 0.022 | ESR1, CASP8, BARD1, PIK3CA, CDH1, RB1CC1, TP53, AKT1 |
cell differentiation in hindbrain (GO:0021533) | NEW | 6.64 | 0.0 | CHEK2, ESR1, AKT1, TP53, CDH1 |
positive regulation of metabolic process (GO:0009893) | - | 1.74 | 0.0 | NBN, PHB, KRAS, BRCA2, AKT1, CASP8, CDH1, BARD1, PIK3CA, FAM175A, RB1CC1, TP53, ESR1, BRCA1, CHEK2, RAD51 |
positive regulation of canonical Wnt signaling pathway (GO:0090263) | NEW | 4.95 | 0.017 | TP53, BRCA1, ESR1, AKT1, CDH1 |
regulation of production of molecular mediator of immune response (GO:0002700) | NEW | 5.1 | 0.005 | ATM, ESR1, CASP8, CDH1, TP53, AKT1 |
regulation of catenin import into nucleus (GO:0035412) | NEW | 6.47 | 0.003 | TP53, AKT1, CDH1, PIK3CA |
positive regulation of protein transport (GO:0051222) | - | 3.61 | 0.016 | ATM, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1, HMMR |
regulation of protein transport (GO:0051223) | - | 3.12 | 0.001 | ATM, KRAS, AKT1, CASP8, BARD1, TP53, CDH1, HMMR, ESR1, PIK3CA, BRCA1, TSG101 |
signal transduction by p53 class mediator (GO:0072331) | - | 4.88 | 0.001 | ATM, NBN, BRCA2, TP53, CDH1, AKT1, BRCA1 |
spindle assembly (GO:0051225) | NEW | 5.57 | 0.024 | ATM, CHEK2, TP53, AKT1 |
regulation of oxidoreductase activity (GO:0051341) | - | 5.27 | 0.004 | PHB, ESR1, TP53, KRAS, CDH1, AKT1 |
negative regulation of transferase activity (GO:0051348) | - | 3.87 | 0.0 | ATM, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
response to interleukin-6 (GO:0070741) | NEW | 6.78 | 0.004 | PHB, ESR1, TP53, AKT1 |
organic cyclic compound metabolic process (GO:1901360) | - | 1.26 | 0.027 | ATM, NBN, XRCC3, BRCA2, AKT1, PALB2, BARD1, TP53, PHB, FAM175A, RB1CC1, KRAS, ESR1, CHEK2, BRCA1, BRIP1, RAD54L, RAD51 |
regulation of establishment of protein localization (GO:0070201) | - | 3.02 | 0.004 | ATM, KRAS, AKT1, CASP8, BARD1, TP53, CDH1, HMMR, ESR1, PIK3CA, BRCA1, TSG101 |
cell cycle arrest (GO:0007050) | - | 4.69 | 0.002 | ATM, NBN, AKT1, PPM1D, BARD1, TP53, KRAS, ESR1, BRCA1, TSG101 |
pattern specification process (GO:0007389) | - | 3.79 | 0.0 | ATM, BRCA2, AKT1, PALB2, PPM1D, TP53, CDH1, PIK3CA, ESR1, BRCA1, BRIP1, CHEK2, RAD51 |
mitotic spindle organization (GO:0007052) | NEW | 6.29 | 0.003 | TP53, CHEK2, AKT1, TSG101 |
cranial nerve development (GO:0021545) | NEW | 6.68 | 0.015 | BRCA1, ESR1, CHEK2, TP53 |
chromosome segregation (GO:0007059) | NEW | 5.06 | 0.015 | ATM, BRCA1, RAD51, TP53, AKT1 |
leukocyte differentiation (GO:0002521) | NEW | 4.13 | 0.005 | ATM, KRAS, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1 |
reproduction (GO:0000003) | NEW | 7.16 | 0.017 | TP53, CHEK2, AKT1, CDH1 |
positive regulation of mesenchymal cell proliferation (GO:0002053) | NEW | 6.4 | 0.047 | CHEK2, ESR1, AKT1, CDH1 |
nucleoside phosphate catabolic process (GO:1901292) | NEW | 5.54 | 0.006 | ATM, PHB, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
cellular response to alcohol (GO:0097306) | - | 6.07 | 0.024 | TP53, BRCA1, ESR1, AKT1, CDH1 |
positive regulation of transport (GO:0051050) | - | 2.9 | 0.019 | ATM, KRAS, AKT1, CASP8, BARD1, TP53, CDH1, PIK3CA, ESR1, BRCA1, HMMR, CHEK2, TSG101 |
mesoderm development (GO:0007498) | NEW | 5.72 | 0.008 | TP53, BRCA1, RAD51, PALB2, CDH1 |
cellular response to inorganic substance (GO:0071241) | - | 4.67 | 0.03 | ATM, TP53, CDH1, RB1CC1, PIK3CA, AKT1 |
negative regulation of cellular component organization (GO:0051129) | - | 3.35 | 0.001 | ATM, KRAS, AKT1, CASP8, RAD51, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
regulation of protein catabolic process (GO:0042176) | - | 3.83 | 0.0 | BRCA2, AKT1, CASP8, BARD1, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2 |
negative regulation of mitotic cell cycle phase transition (GO:1901991) | - | 4.82 | 0.0 | ATM, NBN, ESR1, TP53, CDH1, PIK3CA, AKT1, BRCA1, RAD51 |
regulation of mitotic cell cycle phase transition (GO:1901990) | - | 4.23 | 0.0 | ATM, NBN, BRCA2, AKT1, TP53, CDH1, PIK3CA, ESR1, BRCA1, RAD51 |
intracellular signal transduction (GO:0035556) | - | 2.39 | 0.005 | ATM, NBN, KRAS, BRCA2, CASP8, PIK3CA, RB1CC1, TP53, AKT1, BRCA1, CHEK2 |
response to organic cyclic compound (GO:0014070) | - | 3.07 | 0.025 | PHB, KRAS, AKT1, CASP8, TP53, CDH1, RB1CC1, RAD51, ESR1, PIK3CA, BRCA1, CHEK2, TSG101 |
meiotic nuclear division (GO:0007126) | - | 5.37 | 0.0 | ATM, NBN, BRCA2, TP53, RAD51, AKT1, CHEK2, RAD54L, BRCA1, TSG101 |
positive regulation of protein metabolic process (GO:0051247) | - | 2.43 | 0.0 | ATM, NBN, KRAS, BRCA2, AKT1, CASP8, PPM1D, BARD1, RAD51, TP53, PHB, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
negative regulation of transcription from RNA polymerase II promoter (GO:0000122) | - | 3.12 | 0.0 | PHB, ATM, KRAS, AKT1, CASP8, BARD1, TP53, CDH1, RAD51, ESR1, PIK3CA, BRCA1, CHEK2, TSG101 |
nuclear division (GO:0000280) | - | 3.85 | 0.0 | ATM, NBN, BRCA2, BARD1, TP53, CDH1, RAD51, AKT1, CHEK2, BRCA1, RAD54L, TSG101 |
negative regulation of cell proliferation (GO:0008285) | - | 3.26 | 0.001 | PHB, ATM, KRAS, BRCA2, AKT1, CASP8, PPM1D, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
insulin receptor signaling pathway (GO:0008286) | - | 5.33 | 0.028 | ESR1, TP53, CDH1, KRAS, AKT1, PIK3CA |
regulation of body fluid levels (GO:0050878) | NEW | 3.76 | 0.001 | KRAS, BRCA2, AKT1, CASP8, RAD51, TP53, CDH1, HMMR, ESR1, PIK3CA, BRCA1, CHEK2, TSG101 |
cell proliferation (GO:0008283) | - | 3.23 | 0.0 | ATM, NBN, KRAS, BRCA2, AKT1, CASP8, PALB2, PPM1D, TP53, CDH1, PIK3CA, ESR1, BRCA1, BRIP1, CHEK2, RAD51 |
neurological system process (GO:0050877) | - | 2.64 | 0.007 | ATM, PHB, KRAS, NBN, AKT1, BARD1, TP53, CDH1, NQO2, ESR1, PIK3CA, BRCA1, CHEK2, TSG101 |
positive regulation of T cell activation (GO:0050870) | - | 4.39 | 0.005 | ATM, KRAS, ESR1, CASP8, TP53, CDH1, PIK3CA, AKT1 |
cellular response to DNA damage stimulus (GO:0006974) | - | 3.17 | 0.0 | ATM, NBN, XRCC3, KRAS, BRCA2, AKT1, CASP8, PALB2, CDH1, BARD1, RAD51, TP53, FAM175A, PIK3CA, ESR1, CHEK2, BRCA1, BRIP1, RAD54L, TSG101 |
positive regulation of biological process (GO:0048518) | - | 1.2 | 0.002 | ATM, NBN, XRCC3, KRAS, BRCA2, AKT1, CASP8, CDH1, BARD1, TP53, PHB, FAM175A, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
regulation of cell growth (GO:0001558) | - | 3.75 | 0.026 | PHB, KRAS, AKT1, TP53, CDH1, TSG101, ESR1, BRCA1, CHEK2, HMMR |
eye development (GO:0001654) | NEW | 5.07 | 0.007 | ESR1, CDH1, TP53, AKT1, CHEK2, BRCA1 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978) | - | 7.09 | 0.0 | BRCA1, BRCA2, TP53, CDH1 |
response to oxidative stress (GO:0006979) | NEW | 3.9 | 0.013 | ATM, KRAS, ESR1, CDH1, RB1CC1, TP53, AKT1, BRCA1, CHEK2 |
glycerophospholipid biosynthetic process (GO:0046474) | - | 4.62 | 0.0 | ATM, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1 |
negative regulation of growth (GO:0045926) | - | 4.24 | 0.005 | PHB, KRAS, AKT1, TP53, CDH1, TSG101, ESR1, BRCA1, HMMR |
apoptotic signaling pathway (GO:0097190) | - | 4.12 | 0.0 | ATM, NBN, KRAS, BRCA2, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2 |
extrinsic apoptotic signaling pathway (GO:0097191) | NEW | 5.16 | 0.005 | ESR1, CASP8, TP53, PIK3CA, AKT1, BRCA1 |
intrinsic apoptotic signaling pathway (GO:0097193) | - | 4.69 | 0.0 | ATM, NBN, BRCA2, CASP8, PIK3CA, TP53, AKT1, BRCA1, CHEK2 |
cell cycle process (GO:0022402) | - | 2.75 | 0.0 | ATM, NBN, XRCC3, KRAS, BRCA2, AKT1, CASP8, PPM1D, CDH1, BARD1, RAD51, TP53, FAM175A, PIK3CA, ESR1, BRCA1, BRIP1, CHEK2, TSG101 |
lens development in camera-type eye (GO:0002088) | NEW | 6.09 | 0.028 | BRCA1, ESR1, TP53, AKT1 |
segmentation (GO:0035282) | - | 5.8 | 0.047 | ATM, BRCA1, BRIP1, PALB2, TP53 |
response to hyperoxia (GO:0055093) | NEW | 6.4 | 0.001 | TP53, ESR1, KRAS, AKT1 |
regulation of cell division (GO:0051302) | NEW | 4.88 | 0.0 | ATM, BRCA2, AKT1, PPM1D, BARD1, TP53, CDH1, ESR1, BRCA1, CHEK2, TSG101 |
gamete generation (GO:0007276) | - | 3.61 | 0.0 | ATM, KRAS, BRCA2, AKT1, CASP8, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
response to toxic substance (GO:0009636) | - | 4.88 | 0.011 | KRAS, ESR1, CASP8, CDH1, RB1CC1, TP53, AKT1 |
negative regulation of cellular macromolecule biosynthetic process (GO:2000113) | - | 2.6 | 0.003 | ATM, PHB, KRAS, BRCA2, AKT1, CASP8, BARD1, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, BRIP1, CHEK2, TSG101 |
positive regulation of apoptotic process (GO:0043065) | - | 3.38 | 0.027 | PHB, ATM, KRAS, AKT1, CASP8, BARD1, TP53, CDH1, PIK3CA, ESR1 |
regulation of programmed cell death (GO:0043067) | - | 2.49 | 0.0 | ATM, PHB, KRAS, AKT1, CASP8, PALB2, BARD1, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1 |
negative regulation of apoptotic process (GO:0043066) | - | 3.04 | 0.0 | ATM, KRAS, BRCA2, AKT1, CASP8, PALB2, BARD1, PIK3CA, CDH1, RB1CC1, TP53, ESR1, BRCA1, BRIP1, CHEK2, RAD51 |
positive regulation of leukocyte proliferation (GO:0070665) | NEW | 4.79 | 0.004 | ATM, KRAS, ESR1, CDH1, TP53, AKT1, PIK3CA |
cell division (GO:0051301) | - | 3.68 | 0.002 | ESR1, CDH1, TP53, AKT1, BRCA1, CHEK2, TSG101 |
negative regulation of cell death (GO:0060548) | - | 2.95 | 0.0 | ATM, KRAS, BRCA2, AKT1, CASP8, PALB2, BARD1, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, BRIP1, CHEK2, RAD51 |
regulation of nucleocytoplasmic transport (GO:0046822) | - | 4.33 | 0.006 | AKT1, BARD1, TP53, CDH1, PIK3CA, ESR1, BRCA1, TSG101 |
hepatocyte apoptotic process (GO:0097284) | NEW | 7.16 | 0.004 | CASP8, AKT1, CDH1 |
protein phosphorylation (GO:0006468) | - | 2.89 | 0.043 | PHB, ATM, KRAS, ESR1, TP53, CDH1, RB1CC1, PIK3CA, AKT1, BRCA1, CHEK2, RAD51 |
negative regulation of protein kinase activity (GO:0006469) | NEW | 4.29 | 0.0 | ATM, AKT1, CASP8, TP53, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
regulation of innate immune response (GO:0045088) | - | 3.86 | 0.017 | ATM, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1 |
regulation of lipid metabolic process (GO:0019216) | - | 4.08 | 0.002 | PHB, ESR1, TP53, CDH1, PIK3CA, AKT1, BRCA1, CHEK2, TSG101 |
regulation of nucleobase-containing compound metabolic process (GO:0019219) | - | 1.43 | 0.015 | NBN, PHB, KRAS, BRCA2, AKT1, CDH1, BARD1, RAD51, TP53, FAM175A, RB1CC1, PIK3CA, ESR1, BRCA1, BRIP1, CHEK2, TSG101 |
protein complex assembly (GO:0006461) | - | 2.78 | 0.004 | ATM, PHB, KRAS, BRCA2, AKT1, CASP8, RAD51, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
single-organism developmental process (GO:0044767) | - | 1.49 | 0.027 | ATM, NBN, KRAS, BRCA2, AKT1, CASP8, PALB2, TP53, PHB, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
multi-organism cellular process (GO:0044764) | - | 3.14 | 0.041 | PHB, KRAS, AKT1, CASP8, RAD51, TP53, TSG101, ESR1, PIK3CA, BRCA1, HMMR |
single-organism cellular process (GO:0044763) | - | 0.65 | 0.017 | ATM, PALB2, TP53, FAM175A, RB1CC1, PIK3CA, XRCC3, RAD54L, PHB, CASP8, PPM1D, KRAS, BRCA1, NBN, SLC22A18, BARD1, CDH1, AKT1, BRIP1, BRCA2, RAD51, ESR1, CHEK2, TSG101 |
positive regulation of protein processing (GO:0010954) | NEW | 6.9 | 0.004 | ESR1, CASP8, CDH1, TP53, AKT1, PIK3CA |
regulation of nitric-oxide synthase activity (GO:0050999) | - | 5.9 | 0.028 | ESR1, KRAS, AKT1 |
chromosome organization (GO:0051276) | - | 3.79 | 0.013 | ATM, NBN, PPM1D, TP53, RAD54L, BRCA1, TSG101 |
inner cell mass cell proliferation (GO:0001833) | - | 7.33 | 0.02 | BRCA1, BRCA2, PALB2 |
positive regulation of JNK cascade (GO:0046330) | NEW | 4.98 | 0.018 | ATM, TP53, AKT1, PIK3CA, CDH1 |
positive regulation of peptidyl-lysine acetylation (GO:2000758) | NEW | 6.29 | 0.004 | BRCA1, ESR1, TP53, AKT1 |
negative regulation of cellular process (GO:0048523) | - | 1.41 | 0.0 | PHB, ATM, KRAS, BRCA2, AKT1, CASP8, PPM1D, PALB2, BARD1, TP53, CDH1, RB1CC1, PIK3CA, ESR1, NBN, BRCA1, CHEK2, TSG101 |
regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108) | NEW | 6.9 | 0.036 | BRCA1, TP53, AKT1 |
regulation of T cell apoptotic process (GO:0070232) | NEW | 6.2 | 0.001 | KRAS, TP53, CASP8, ESR1, PIK3CA |
positive regulation of defense response (GO:0031349) | - | 3.83 | 0.001 | ATM, KRAS, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, HMMR |
regulation of neuron apoptotic process (GO:0043523) | - | 4.47 | 0.007 | ATM, KRAS, ESR1, CASP8, TP53, PIK3CA, AKT1, CHEK2 |
mitochondrial membrane organization (GO:0007006) | - | 5.2 | 0.0 | ATM, PHB, BRCA1, TP53, AKT1 |
regulation of defense response (GO:0031347) | - | 3.11 | 0.009 | ATM, KRAS, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, HMMR |
positive regulation of cell projection organization (GO:0031346) | NEW | 3.99 | 0.003 | KRAS, ESR1, BARD1, TP53, CDH1, PIK3CA, AKT1, BRCA1, CHEK2 |
single-organism metabolic process (GO:0044710) | - | 1.63 | 0.0 | ATM, PHB, XRCC3, KRAS, BRCA2, AKT1, PALB2, BARD1, RAD51, TP53, FAM175A, RB1CC1, NQO2, ESR1, PIK3CA, NBN, CHEK2, BRCA1, BRIP1, RAD54L, HMMR |
neuron projection guidance (GO:0097485) | NEW | 4.43 | 0.001 | ATM, KRAS, ESR1, TP53, CDH1, RB1CC1, PIK3CA, AKT1, BRCA1, CHEK2, RAD51 |
response to indole-3-methanol (GO:0071680) | - | 8.12 | 0.029 | BRCA1, CDH1 |
positive regulation of cell cycle (GO:0045787) | - | 3.94 | 0.003 | ATM, BRCA2, ESR1, CDH1, TP53, AKT1, CHEK2 |
response to epidermal growth factor (GO:0070849) | NEW | 6.29 | 0.015 | TP53, BRCA1, AKT1, CDH1 |
regulation of inflammatory response (GO:0050727) | NEW | 4.03 | 0.027 | ATM, ESR1, TP53, CDH1, PIK3CA, AKT1, CHEK2, HMMR |
negative regulation of neuron differentiation (GO:0045665) | NEW | 4.45 | 0.001 | ESR1, CDH1, TP53, AKT1, CHEK2, BRCA1 |
regulation of neuron differentiation (GO:0045664) | NEW | 3.39 | 0.004 | ATM, KRAS, BRCA2, AKT1, BARD1, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2 |
negative regulation of myoblast differentiation (GO:0045662) | NEW | 6.55 | 0.045 | TP53, AKT1, CDH1 |
regulation of signal transduction by p53 class mediator (GO:1901796) | - | 4.63 | 0.024 | ATM, ESR1, TP53, CDH1 |
ribonucleoside catabolic process (GO:0042454) | NEW | 6.55 | 0.003 | PHB, ATM, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
hyaluronan metabolic process (GO:0030212) | - | 6.29 | 0.006 | ATM, CDH1, AKT1, HMMR |
positive regulation of DNA metabolic process (GO:0051054) | - | 4.49 | 0.0 | ATM, ESR1, TP53, FAM175A, CDH1, AKT1, BRCA1, RAD51 |
negative regulation of DNA metabolic process (GO:0051053) | - | 4.98 | 0.0 | ATM, BRCA2, ESR1, CDH1, TP53, AKT1, CHEK2 |
regulation of DNA metabolic process (GO:0051052) | - | 3.87 | 0.0 | ATM, NBN, BRCA2, AKT1, CDH1, TP53, FAM175A, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
histone H3 acetylation (GO:0043966) | NEW | 5.92 | 0.038 | CHEK2, BRCA2, ESR1, TP53 |
T cell differentiation (GO:0030217) | NEW | 5.11 | 0.028 | ESR1, TP53, CDH1, KRAS, AKT1, BRCA1 |
ATP metabolic process (GO:0046034) | NEW | 4.98 | 0.002 | PHB, ATM, XRCC3, BRCA2, AKT1, TP53, ESR1, BRCA1, BRIP1, RAD51 |
response to metal ion (GO:0010038) | - | 3.91 | 0.005 | KRAS, ESR1, CASP8, CDH1, RB1CC1, TP53, AKT1, PIK3CA, CHEK2 |
negative regulation of response to DNA damage stimulus (GO:2001021) | NEW | 5.78 | 0.001 | TP53, BRCA1, ESR1, AKT1, CDH1 |
regulation of response to DNA damage stimulus (GO:2001020) | - | 4.74 | 0.0 | ATM, AKT1, PPM1D, TP53, FAM175A, CDH1, ESR1, BRCA1, RAD51 |
response to inorganic substance (GO:0010035) | - | 3.56 | 0.002 | ATM, KRAS, AKT1, CASP8, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2 |
response to other organism (GO:0051707) | NEW | 3.48 | 0.031 | ATM, AKT1, CASP8, PPM1D, RAD51, TP53, CDH1, PIK3CA, ESR1, HMMR |
stem cell maintenance (GO:0019827) | NEW | 4.83 | 0.045 | ATM, ESR1, CDH1, TP53, AKT1, BRCA1 |
cellular response to extracellular stimulus (GO:0031668) | - | 4.57 | 0.006 | KRAS, ESR1, CDH1, RB1CC1, TP53, AKT1, BRCA1 |
cellular response to nutrient levels (GO:0031669) | - | 4.7 | 0.002 | KRAS, ESR1, CDH1, RB1CC1, TP53, AKT1, BRCA1 |
negative regulation of programmed cell death (GO:0043069) | - | 3.02 | 0.0 | ATM, KRAS, BRCA2, AKT1, CASP8, PALB2, BARD1, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, BRIP1, CHEK2, RAD51 |
regulation of DNA recombination (GO:0000018) | NEW | 5.65 | 0.004 | ATM, NBN, ESR1, RAD51, TP53 |
positive regulation of programmed cell death (GO:0043068) | - | 3.38 | 0.028 | PHB, ATM, KRAS, AKT1, CASP8, BARD1, TP53, CDH1, PIK3CA, ESR1 |
chromatin modification (GO:0016568) | NEW | 4.06 | 0.0 | ATM, NBN, KRAS, BRCA2, AKT1, CDH1, BARD1, TP53, PHB, FAM175A, RAD51, ESR1, BRCA1, CHEK2, TSG101 |
covalent chromatin modification (GO:0016569) | - | 3.89 | 0.0 | PHB, ATM, BRCA2, AKT1, TP53, ESR1, NBN, BRCA1, CHEK2, RAD51 |
leukocyte activation (GO:0045321) | - | 3.76 | 0.0 | ATM, NBN, KRAS, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, HMMR |
nitrogen compound metabolic process (GO:0006807) | - | 1.13 | 0.015 | ATM, NBN, XRCC3, KRAS, BRCA2, AKT1, PALB2, BARD1, TP53, PHB, FAM175A, RB1CC1, RAD51, ESR1, CHEK2, BRCA1, BRIP1, RAD54L, HMMR |
neuron migration (GO:0001764) | NEW | 5.0 | 0.019 | ATM, ESR1, CDH1, TP53, AKT1, PIK3CA, CHEK2 |
nucleoside monophosphate metabolic process (GO:0009123) | NEW | 4.54 | 0.006 | PHB, ATM, XRCC3, BRCA2, AKT1, TP53, ESR1, BRCA1, BRIP1, RAD51 |
purine nucleotide catabolic process (GO:0006195) | NEW | 6.07 | 0.004 | ATM, PHB, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
positive regulation of myeloid leukocyte differentiation (GO:0002763) | NEW | 5.82 | 0.004 | BRCA1, CASP8, ESR1, CDH1, AKT1 |
cellular macromolecule catabolic process (GO:0044265) | - | 3.19 | 0.0 | ATM, XRCC3, KRAS, BRCA2, AKT1, CASP8, PPM1D, RAD51, TP53, CDH1, PIK3CA, ESR1, CHEK2, RAD54L, BRCA1, TSG101 |
cellular macromolecule metabolic process (GO:0044260) | - | 0.93 | 0.032 | ATM, PHB, XRCC3, BRCA2, AKT1, PPM1D, PALB2, BARD1, RAD51, TP53, FAM175A, RB1CC1, PIK3CA, ESR1, NBN, CHEK2, BRCA1, BRIP1, RAD54L, TSG101 |
blood vessel development (GO:0001568) | NEW | 4.95 | 0.019 | ESR1, CDH1, TP53, AKT1, CHEK2, TSG101 |
regulation of JAK-STAT cascade (GO:0046425) | NEW | 4.78 | 0.001 | ESR1, CDH1, TP53, AKT1, PIK3CA, CHEK2 |
cellular response to fibroblast growth factor stimulus (GO:0044344) | NEW | 6.4 | 0.012 | KRAS, ESR1, CDH1, TP53, AKT1, PIK3CA, CHEK2 |
negative regulation of MAPK cascade (GO:0043409) | - | 4.74 | 0.0 | ATM, KRAS, CASP8, PIK3CA, CDH1, TP53, AKT1, RAD51 |
regulation of cell projection organization (GO:0031344) | NEW | 3.38 | 0.001 | KRAS, AKT1, BARD1, RAD51, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
organ morphogenesis (GO:0009887) | NEW | 3.55 | 0.0 | ATM, BRCA2, AKT1, PALB2, RAD51, TP53, CDH1, RB1CC1, TSG101, ESR1, BRCA1, BRIP1, CHEK2, HMMR |
hexose metabolic process (GO:0019318) | - | 4.64 | 0.001 | KRAS, ESR1, TP53, CDH1, TSG101, AKT1, PIK3CA, RAD51 |
tissue development (GO:0009888) | - | 3.27 | 0.0 | NBN, BRCA2, AKT1, CASP8, PALB2, BARD1, TP53, CDH1, RB1CC1, RAD51, ESR1, BRCA1, BRIP1, CHEK2, TSG101 |
somatic stem cell maintenance (GO:0035019) | NEW | 5.52 | 0.009 | TP53, BRCA1, ESR1, KRAS, AKT1 |
cellular nitrogen compound metabolic process (GO:0034641) | - | 1.22 | 0.024 | ATM, PHB, XRCC3, BRCA2, AKT1, PALB2, BARD1, TP53, FAM175A, RB1CC1, KRAS, ESR1, NBN, CHEK2, BRCA1, BRIP1, RAD54L, RAD51 |
cellular response to ionizing radiation (GO:0071479) | - | 5.78 | 0.033 | ATM, RAD51, TP53, AKT1 |
organophosphate biosynthetic process (GO:0090407) | - | 3.67 | 0.006 | PHB, ATM, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1, RAD51 |
endocytosis (GO:0006897) | NEW | 3.69 | 0.004 | KRAS, AKT1, CASP8, TP53, CDH1, TSG101, ESR1, PIK3CA, CHEK2, HMMR |
anterior/posterior pattern specification (GO:0009952) | - | 4.71 | 0.0 | ATM, BRCA2, AKT1, PALB2, TP53, CDH1, ESR1, BRCA1, BRIP1, CHEK2 |
phospholipid biosynthetic process (GO:0008654) | - | 4.39 | 0.001 | ATM, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1 |
regulation of epithelial to mesenchymal transition (GO:0010717) | NEW | 5.55 | 0.01 | TP53, RB1CC1, ESR1, AKT1, CDH1 |
response to stimulus (GO:0050896) | - | 1.22 | 0.0 | ATM, PALB2, TP53, FAM175A, RB1CC1, PIK3CA, XRCC3, RAD54L, PHB, CASP8, PPM1D, KRAS, BRCA1, NBN, BARD1, CDH1, AKT1, BRIP1, BRCA2, NQO2, ESR1, CHEK2, RAD51 |
regulation of transferase activity (GO:0051338) | - | 2.88 | 0.009 | PHB, ATM, KRAS, NBN, AKT1, CASP8, TP53, CDH1, RAD51, ESR1, PIK3CA, BRCA1, CHEK2, HMMR |
positive regulation of leukocyte activation (GO:0002696) | - | 4.0 | 0.008 | ATM, KRAS, BRCA2, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1 |
positive regulation of protein maturation (GO:1903319) | NEW | 6.84 | 0.004 | ESR1, CASP8, CDH1, TP53, AKT1, PIK3CA |
camera-type eye development (GO:0043010) | NEW | 5.36 | 0.021 | TP53, BRCA1, ESR1, CHEK2, AKT1 |
regulation of cell morphogenesis (GO:0022604) | NEW | 3.4 | 0.009 | KRAS, AKT1, CASP8, BARD1, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2 |
cellular response to gamma radiation (GO:0071480) | - | 6.78 | 0.013 | ATM, TP53, AKT1 |
regulation of organelle organization (GO:0033043) | - | 2.72 | 0.001 | ATM, XRCC3, KRAS, AKT1, CASP8, PPM1D, BARD1, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
response to radiation (GO:0009314) | - | 3.69 | 0.0 | PHB, ATM, KRAS, BRCA2, CASP8, PALB2, PPM1D, TP53, FAM175A, RAD51, AKT1, CHEK2, RAD54L, BRCA1, HMMR |
mammary gland epithelial cell proliferation (GO:0033598) | NEW | 7.24 | 0.032 | ESR1, TP53, AKT1 |
regulation of mammary gland epithelial cell proliferation (GO:0033599) | NEW | 6.84 | 0.045 | BRCA2, ESR1, TP53 |
trigeminal nerve development (GO:0021559) | NEW | 8.34 | 0.0 | CHEK2, ESR1, TP53 |
single-organism process (GO:0044699) | - | 0.48 | 0.01 | ATM, PALB2, TP53, FAM175A, RB1CC1, PIK3CA, XRCC3, RAD54L, PHB, CASP8, PPM1D, KRAS, BRCA1, NBN, SLC22A18, BARD1, CDH1, AKT1, BRIP1, HMMR, BRCA2, NQO2, RAD51, ESR1, CHEK2, TSG101 |
regulation of neurogenesis (GO:0050767) | NEW | 3.21 | 0.032 | ATM, KRAS, BRCA2, AKT1, BARD1, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2 |
negative regulation of protein metabolic process (GO:0051248) | - | 2.82 | 0.0 | ATM, KRAS, BRCA2, AKT1, CASP8, BARD1, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, HMMR |
response to ionizing radiation (GO:0010212) | - | 4.74 | 0.0 | ATM, BRCA2, PALB2, TP53, FAM175A, AKT1, CHEK2, BRCA1, RAD54L, RAD51 |
positive regulation of phosphorus metabolic process (GO:0010562) | - | 2.78 | 0.002 | PHB, ATM, KRAS, NBN, AKT1, CASP8, PPM1D, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
negative regulation of phosphorus metabolic process (GO:0010563) | - | 3.45 | 0.002 | ATM, KRAS, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
regulation of cell cycle process (GO:0010564) | - | 3.5 | 0.0 | ATM, NBN, XRCC3, BRCA2, AKT1, PPM1D, BARD1, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
regulation of cellular ketone metabolic process (GO:0010565) | - | 4.67 | 0.001 | ESR1, TP53, CDH1, PIK3CA, AKT1, BRCA1, CHEK2, TSG101 |
regulation of cell morphogenesis involved in differentiation (GO:0010769) | NEW | 3.91 | 0.028 | KRAS, ESR1, CDH1, RB1CC1, TP53, AKT1, PIK3CA, BRCA1, CHEK2 |
regulation of morphogenesis of a branching structure (GO:0060688) | NEW | 5.76 | 0.008 | CHEK2, BRCA1, ESR1, AKT1, CDH1 |
central nervous system neuron differentiation (GO:0021953) | NEW | 5.17 | 0.023 | ATM, ESR1, CDH1, TP53, AKT1, CHEK2 |
regulation of intrinsic apoptotic signaling pathway (GO:2001242) | - | 4.74 | 0.05 | ESR1, CASP8, CDH1, TP53, AKT1, BRCA1 |
reproductive structure development (GO:0048608) | - | 4.08 | 0.0 | ATM, BRCA2, AKT1, CASP8, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
multicellular organismal reproductive process (GO:0048609) | - | 3.35 | 0.002 | ATM, KRAS, BRCA2, AKT1, CASP8, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
regulation of stress-activated protein kinase signaling cascade (GO:0070302) | NEW | 4.44 | 0.025 | ATM, ESR1, CASP8, TP53, CDH1, PIK3CA, AKT1 |
cellular response to lipid (GO:0071396) | NEW | 3.96 | 0.029 | ATM, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1, TSG101 |
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304) | NEW | 4.82 | 0.0 | ATM, ESR1, CASP8, TP53, CDH1, PIK3CA, AKT1 |
regulation of toll-like receptor signaling pathway (GO:0034121) | NEW | 5.88 | 0.04 | ESR1, TP53, AKT1, PIK3CA |
male gamete generation (GO:0048232) | NEW | 3.7 | 0.003 | ATM, KRAS, BRCA2, AKT1, CASP8, RAD51, TP53, CDH1, PIK3CA, ESR1, TSG101 |
nerve development (GO:0021675) | NEW | 6.29 | 0.003 | TP53, BRCA1, ESR1, CHEK2, CDH1 |
negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | NEW | 7.43 | 0.015 | AKT1, TP53, PIK3CA |
single-organism intracellular transport (GO:1902582) | NEW | 3.59 | 0.047 | ATM, PHB, KRAS, AKT1, CASP8, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
carbohydrate derivative catabolic process (GO:1901136) | NEW | 4.61 | 0.0 | PHB, ATM, XRCC3, KRAS, BRCA2, AKT1, TP53, CDH1, RAD51, ESR1, PIK3CA, BRCA1, BRIP1, CHEK2, HMMR |
response to drug (GO:0042493) | - | 3.71 | 0.002 | KRAS, ESR1, CASP8, TP53, CDH1, RB1CC1, PIK3CA, AKT1, RAD54L, CHEK2, RAD51 |
response to molecule of bacterial origin (GO:0002237) | NEW | 3.99 | 0.033 | ATM, KRAS, ESR1, CASP8, TP53, CDH1, PIK3CA, AKT1 |
system development (GO:0048731) | - | 2.92 | 0.048 | PHB, KRAS, AKT1, CASP8, BARD1, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
central nervous system projection neuron axonogenesis (GO:0021952) | NEW | 6.73 | 0.006 | BRCA1, ESR1, TP53, AKT1 |
negative regulation of ERK1 and ERK2 cascade (GO:0070373) | NEW | 5.74 | 0.04 | TP53, KRAS, AKT1, CDH1 |
regulation of ERK1 and ERK2 cascade (GO:0070372) | - | 4.23 | 0.015 | ESR1, CASP8, TP53, CDH1, PIK3CA, AKT1, RAD51 |
embryonic limb morphogenesis (GO:0030326) | NEW | 5.24 | 0.005 | ESR1, CDH1, TP53, AKT1, CHEK2, BRCA1 |
regulation of peptidyl-serine phosphorylation (GO:0033135) | - | 4.98 | 0.009 | ATM, ESR1, KRAS, CDH1, AKT1, PIK3CA |
positive regulation of cell activation (GO:0050867) | - | 3.97 | 0.001 | ATM, KRAS, BRCA2, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1 |
regulation of DNA methylation (GO:0044030) | - | 6.78 | 0.001 | BRCA1, TP53, AKT1, PIK3CA |
regulation of T cell activation (GO:0050863) | - | 4.05 | 0.005 | ATM, KRAS, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1 |
purine-containing compound catabolic process (GO:0072523) | NEW | 5.92 | 0.005 | ATM, PHB, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
negative regulation of protein serine/threonine kinase activity (GO:0071901) | NEW | 4.92 | 0.014 | CASP8, PIK3CA, TP53, AKT1, CHEK2, BRCA1 |
osteoblast differentiation (GO:0001649) | - | 5.05 | 0.036 | PHB, ESR1, TP53, KRAS, CDH1, AKT1 |
regulation of protein serine/threonine kinase activity (GO:0071900) | - | 3.58 | 0.0 | ATM, PHB, KRAS, BRCA2, AKT1, CASP8, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, HMMR |
chromatin organization (GO:0006325) | - | 3.28 | 0.0 | PHB, ATM, KRAS, BRCA2, AKT1, CDH1, BARD1, TP53, FAM175A, RAD51, ESR1, NBN, BRCA1, CHEK2, TSG101 |
regulation of apoptotic process (GO:0042981) | - | 2.5 | 0.0 | ATM, PHB, KRAS, AKT1, CASP8, PALB2, BARD1, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1 |
regulation of cell adhesion mediated by integrin (GO:0033628) | NEW | 6.04 | 0.036 | TP53, AKT1, CDH1, PIK3CA |
regulation of cell cycle arrest (GO:0071156) | - | 5.05 | 0.002 | ATM, ESR1, CDH1, TP53, AKT1, BRCA1 |
positive regulation of mitotic cell cycle (GO:0045931) | - | 4.98 | 0.0 | TP53, ESR1, BRCA2, KRAS, AKT1 |
positive regulation of nucleobase-containing compound metabolic process (GO:0045935) | - | 2.35 | 0.015 | PHB, BRCA2, ESR1, TP53, FAM175A, CDH1, AKT1, BRCA1, CHEK2, RAD51 |
negative regulation of nucleobase-containing compound metabolic process (GO:0045934) | - | 2.55 | 0.0 | ATM, PHB, KRAS, BRCA2, AKT1, CASP8, BARD1, TP53, CDH1, RAD51, ESR1, PIK3CA, NBN, BRCA1, BRIP1, CHEK2, TSG101 |
positive regulation of phosphate metabolic process (GO:0045937) | - | 2.78 | 0.002 | ATM, NBN, KRAS, AKT1, CASP8, PPM1D, TP53, PHB, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
negative regulation of phosphate metabolic process (GO:0045936) | - | 3.45 | 0.002 | ATM, KRAS, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
embryonic hindlimb morphogenesis (GO:0035116) | NEW | 6.36 | 0.022 | CHEK2, ESR1, TP53, CDH1 |
genitalia morphogenesis (GO:0035112) | NEW | 7.43 | 0.017 | BRCA1, ESR1, TP53 |
embryonic appendage morphogenesis (GO:0035113) | NEW | 5.24 | 0.005 | ESR1, CDH1, TP53, AKT1, CHEK2, BRCA1 |
Ras protein signal transduction (GO:0007265) | - | 4.76 | 0.0 | KRAS, ESR1, CDH1, RB1CC1, TP53, AKT1, PIK3CA, CHEK2 |
small GTPase mediated signal transduction (GO:0007264) | - | 3.85 | 0.012 | ATM, KRAS, ESR1, TP53, CDH1, RB1CC1, PIK3CA, AKT1, CHEK2, RAD51 |
lipid biosynthetic process (GO:0008610) | - | 3.49 | 0.004 | ATM, KRAS, AKT1, CASP8, BARD1, TP53, CDH1, PIK3CA, ESR1, BRCA1, TSG101 |
organelle organization (GO:0006996) | - | 2.02 | 0.001 | PHB, ATM, KRAS, BRCA2, TP53, RB1CC1, RAD51, AKT1, NBN, CHEK2, RAD54L, BRCA1, TSG101 |
response to abiotic stimulus (GO:0009628) | - | 2.8 | 0.0 | ATM, NBN, KRAS, BRCA2, AKT1, CASP8, PALB2, CDH1, PPM1D, RAD51, TP53, PHB, FAM175A, RB1CC1, PIK3CA, ESR1, CHEK2, BRCA1, RAD54L, HMMR |
carbohydrate metabolic process (GO:0005975) | - | 3.26 | 0.02 | ATM, KRAS, AKT1, CASP8, RAD51, TP53, CDH1, HMMR, ESR1, PIK3CA, BRCA1, TSG101 |
regulation of leukocyte apoptotic process (GO:2000106) | NEW | 5.33 | 0.003 | ESR1, CASP8, KRAS, TP53, AKT1, PIK3CA |
DNA metabolic process (GO:0006259) | - | 3.09 | 0.0 | ATM, PHB, XRCC3, BRCA2, AKT1, PPM1D, PALB2, BARD1, TP53, FAM175A, RAD51, ESR1, PIK3CA, NBN, CHEK2, BRCA1, BRIP1, RAD54L, TSG101 |
symbiosis, encompassing mutualism through parasitism (GO:0044403) | - | 3.15 | 0.037 | PHB, KRAS, AKT1, CASP8, RAD51, TP53, TSG101, ESR1, PIK3CA, BRCA1, HMMR |
positive regulation of cellular process (GO:0048522) | - | 1.3 | 0.0 | ATM, NBN, XRCC3, KRAS, BRCA2, AKT1, CASP8, CDH1, BARD1, TP53, PHB, FAM175A, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
negative regulation of apoptotic signaling pathway (GO:2001234) | - | 4.42 | 0.047 | ESR1, CASP8, CDH1, RB1CC1, TP53, AKT1, BRCA1 |
regulation of extrinsic apoptotic signaling pathway (GO:2001236) | - | 4.69 | 0.001 | KRAS, CASP8, CDH1, RB1CC1, TP53, AKT1, BRCA1, HMMR |
anatomical structure homeostasis (GO:0060249) | - | 4.25 | 0.001 | ATM, NBN, ESR1, BARD1, TP53, RB1CC1, KRAS, AKT1, BRCA1 |
protein dephosphorylation (GO:0006470) | NEW | 4.47 | 0.004 | CASP8, PPM1D, CDH1, TP53, AKT1, CHEK2, RAD51 |
protein acetylation (GO:0006473) | NEW | 4.86 | 0.007 | BRCA2, ESR1, TP53, AKT1, CHEK2, TSG101 |
cell development (GO:0048468) | - | 3.28 | 0.031 | ATM, KRAS, BRCA2, AKT1, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
cell maturation (GO:0048469) | NEW | 4.98 | 0.0 | KRAS, BRCA2, ESR1, CDH1, TP53, AKT1, CHEK2, RAD51 |
regulation of Wnt signaling pathway (GO:0030111) | NEW | 3.98 | 0.022 | ESR1, CASP8, TP53, CDH1, PIK3CA, AKT1, BRCA1, CHEK2 |
response to alkaloid (GO:0043279) | NEW | 4.83 | 0.037 | BRCA2, CASP8, PIK3CA, TP53, AKT1, RAD51 |
purine ribonucleoside catabolic process (GO:0046130) | NEW | 7.16 | 0.003 | PHB, ATM, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
cellular component organization or biogenesis (GO:0071840) | - | 1.22 | 0.006 | ATM, NBN, KRAS, BRCA2, AKT1, CASP8, CDH1, TP53, PHB, FAM175A, RB1CC1, RAD51, ESR1, CHEK2, RAD54L, BRCA1, TSG101 |
negative regulation of signal transduction (GO:0009968) | - | 2.75 | 0.032 | PHB, ATM, KRAS, AKT1, CASP8, TP53, CDH1, RB1CC1, RAD51, ESR1, PIK3CA, BRCA1, CHEK2, HMMR |
positive regulation of signal transduction (GO:0009967) | - | 2.5 | 0.004 | ATM, PHB, KRAS, AKT1, CASP8, PPM1D, BARD1, RAD51, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, HMMR |
rhythmic process (GO:0048511) | - | 4.02 | 0.047 | ATM, BRCA2, ESR1, TP53, CDH1, AKT1, CHEK2, RAD51 |
sensory organ development (GO:0007423) | NEW | 4.82 | 0.034 | ESR1, CDH1, TP53, AKT1, CHEK2, BRCA1 |
negative regulation of cell development (GO:0010721) | NEW | 4.02 | 0.031 | KRAS, ESR1, CDH1, RB1CC1, TP53, AKT1, PIK3CA |
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124) | - | 5.78 | 0.025 | CASP8, ESR1, TP53, AKT1 |
negative regulation of biological process (GO:0048519) | - | 1.33 | 0.0 | PHB, ATM, KRAS, BRCA2, AKT1, CASP8, PPM1D, PALB2, BARD1, TP53, CDH1, RB1CC1, PIK3CA, ESR1, NBN, BRCA1, CHEK2, TSG101 |
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122) | - | 4.27 | 0.046 | ATM, KRAS, ESR1, CASP8, TP53, PIK3CA, AKT1 |
regulation of cell proliferation (GO:0042127) | - | 2.41 | 0.001 | PHB, ATM, KRAS, BRCA2, AKT1, PPM1D, TP53, CDH1, ESR1, BRCA1, TSG101 |
regulation of lymphocyte apoptotic process (GO:0070228) | NEW | 5.7 | 0.009 | KRAS, TP53, CASP8, ESR1, PIK3CA |
cell-substrate adhesion (GO:0031589) | NEW | 4.75 | 0.0 | ATM, KRAS, ESR1, CDH1, RB1CC1, TP53, AKT1, TSG101 |
sensory perception of sound (GO:0007605) | NEW | 4.82 | 0.01 | KRAS, ESR1, CDH1, TP53, AKT1, BRCA1, TSG101 |
regulation of T cell proliferation (GO:0042129) | NEW | 4.74 | 0.004 | ATM, KRAS, ESR1, CASP8, CDH1, TP53, AKT1 |
negative regulation of epithelial cell proliferation (GO:0050680) | NEW | 4.98 | 0.002 | KRAS, BRCA2, ESR1, CDH1, TP53, AKT1, TSG101 |
developmental process involved in reproduction (GO:0003006) | - | 3.36 | 0.034 | ATM, BRCA2, AKT1, CASP8, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
regionalization (GO:0003002) | - | 4.24 | 0.0 | ATM, BRCA2, AKT1, PALB2, PPM1D, TP53, CDH1, PIK3CA, ESR1, BRCA1, BRIP1, CHEK2 |
negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433) | NEW | 4.82 | 0.007 | PHB, ATM, KRAS, ESR1, CDH1, TP53, AKT1 |
cell aging (GO:0007569) | - | 5.54 | 0.0 | ATM, BRCA2, CDH1, TP53, AKT1, CHEK2 |
multi-organism reproductive process (GO:0044703) | NEW | 4.82 | 0.031 | BRCA2, ESR1, CDH1, TP53, AKT1, PIK3CA, CHEK2 |
organonitrogen compound catabolic process (GO:1901565) | NEW | 3.91 | 0.0 | ATM, PHB, XRCC3, KRAS, BRCA2, AKT1, CASP8, BARD1, TP53, CDH1, RAD51, ESR1, PIK3CA, BRCA1, BRIP1, CHEK2, HMMR |
response to organonitrogen compound (GO:0010243) | - | 3.2 | 0.01 | ATM, KRAS, BRCA2, AKT1, CASP8, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
cellular response to stress (GO:0033554) | - | 2.51 | 0.0 | ATM, NBN, BRCA2, XRCC3, PALB2, BARD1, TP53, FAM175A, RB1CC1, AKT1, CHEK2, BRCA1, BRIP1, RAD54L, RAD51 |
regulation of cellular component size (GO:0032535) | - | 4.21 | 0.01 | KRAS, ESR1, CDH1, RB1CC1, TP53, AKT1, RAD51 |
negative regulation of kinase activity (GO:0033673) | NEW | 4.22 | 0.001 | ATM, AKT1, CASP8, TP53, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
ovulation cycle process (GO:0022602) | NEW | 5.25 | 0.0 | ATM, BRCA2, ESR1, CDH1, AKT1, CHEK2, RAD51 |
nucleoside triphosphate metabolic process (GO:0009141) | NEW | 4.61 | 0.01 | PHB, ATM, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
nucleoside triphosphate catabolic process (GO:0009143) | NEW | 7.24 | 0.002 | ATM, PHB, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
purine nucleoside triphosphate metabolic process (GO:0009144) | NEW | 4.76 | 0.007 | PHB, ATM, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
purine nucleoside triphosphate catabolic process (GO:0009146) | NEW | 7.94 | 0.002 | PHB, ATM, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
developmental maturation (GO:0021700) | NEW | 4.7 | 0.0 | KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRCA1, CHEK2 |
signal transduction involved in DNA integrity checkpoint (GO:0072401) | - | 5.55 | 0.038 | ATM, CHEK2, ESR1, TP53 |
positive regulation of cell cycle process (GO:0090068) | - | 4.25 | 0.015 | ATM, XRCC3, ESR1, TP53, CDH1, PIK3CA, AKT1, BRCA1 |
G2 DNA damage checkpoint (GO:0031572) | - | 6.26 | 0.0 | ATM, NBN, TP53, FAM175A, AKT1, BRCA1 |
DNA integrity checkpoint (GO:0031570) | - | 5.25 | 0.0 | ATM, NBN, TP53, FAM175A, PIK3CA, AKT1, BRCA1, BRIP1, CHEK2 |
regulation of kinase activity (GO:0043549) | - | 3.07 | 0.003 | PHB, ATM, KRAS, NBN, AKT1, CASP8, TP53, CDH1, RAD51, ESR1, PIK3CA, BRCA1, CHEK2, HMMR |
regulation of anatomical structure size (GO:0090066) | - | 3.78 | 0.017 | KRAS, ESR1, CDH1, RB1CC1, TP53, AKT1, BRCA1, RAD51 |
histone modification (GO:0016570) | - | 3.91 | 0.0 | PHB, ATM, BRCA2, AKT1, TP53, ESR1, NBN, BRCA1, CHEK2, RAD51 |
cellular response to molecule of bacterial origin (GO:0071219) | NEW | 4.88 | 0.016 | ATM, ESR1, CDH1, TP53, AKT1, PIK3CA |
cellular response to biotic stimulus (GO:0071216) | NEW | 4.76 | 0.0 | ATM, ESR1, TP53, CDH1, PIK3CA, AKT1, RAD54L, RAD51 |
cellular response to abiotic stimulus (GO:0071214) | - | 4.15 | 0.025 | ATM, CASP8, PALB2, PIK3CA, CDH1, TP53, AKT1, BRCA1, RAD51 |
anatomical structure formation involved in morphogenesis (GO:0048646) | - | 3.01 | 0.0 | ATM, KRAS, BRCA2, AKT1, CASP8, PALB2, RAD51, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, BRIP1, CHEK2, HMMR |
internal peptidyl-lysine acetylation (GO:0018393) | NEW | 5.05 | 0.003 | BRCA2, ESR1, TP53, AKT1, CHEK2, TSG101 |
peptidyl-lysine acetylation (GO:0018394) | NEW | 5.03 | 0.003 | BRCA2, ESR1, TP53, AKT1, CHEK2, TSG101 |
sensory perception of mechanical stimulus (GO:0050954) | NEW | 4.79 | 0.001 | KRAS, ESR1, CDH1, TP53, AKT1, BRCA1, CHEK2, TSG101 |
heterocycle catabolic process (GO:0046700) | NEW | 3.82 | 0.0 | PHB, ATM, XRCC3, KRAS, BRCA2, AKT1, CASP8, PPM1D, TP53, CDH1, RAD51, ESR1, PIK3CA, RAD54L, BRIP1, CHEK2, TSG101 |
response to stress (GO:0006950) | - | 1.8 | 0.0 | ATM, NBN, KRAS, BRCA2, XRCC3, CASP8, PALB2, BARD1, TP53, FAM175A, RB1CC1, PIK3CA, AKT1, CHEK2, BRCA1, BRIP1, RAD54L, RAD51 |
negative regulation of intracellular signal transduction (GO:1902532) | - | 3.63 | 0.001 | ATM, KRAS, AKT1, CASP8, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, HMMR |
regulation of protein import into nucleus (GO:0042306) | - | 4.54 | 0.015 | ESR1, TP53, CDH1, PIK3CA, AKT1, BRCA1, TSG101 |
cellular response to indole-3-methanol (GO:0071681) | - | 8.12 | 0.029 | BRCA1, CDH1 |
proteolysis involved in cellular protein catabolic process (GO:0051603) | - | 3.59 | 0.027 | PHB, ATM, KRAS, CASP8, TP53, CDH1, BRCA1, TSG101 |
cellular nitrogen compound catabolic process (GO:0044270) | NEW | 3.8 | 0.0 | PHB, ATM, XRCC3, KRAS, BRCA2, AKT1, CASP8, PPM1D, BARD1, TP53, CDH1, RAD51, ESR1, PIK3CA, RAD54L, BRIP1, CHEK2, TSG101 |
protein maturation (GO:0051604) | NEW | 4.48 | 0.009 | KRAS, ESR1, CASP8, TP53, CDH1, PIK3CA, AKT1, TSG101 |
negative regulation of protein modification process (GO:0031400) | - | 3.4 | 0.0 | ATM, KRAS, BRCA2, AKT1, CASP8, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, HMMR |
positive regulation of protein modification process (GO:0031401) | - | 2.7 | 0.0 | ATM, NBN, KRAS, BRCA2, AKT1, CASP8, PPM1D, RAD51, TP53, PHB, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
response to increased oxygen levels (GO:0036296) | NEW | 6.4 | 0.001 | TP53, KRAS, ESR1, AKT1 |
cell activation (GO:0001775) | - | 3.47 | 0.0 | ATM, NBN, KRAS, BRCA2, AKT1, CASP8, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, HMMR |
DNA strand renaturation (GO:0000733) | - | 7.53 | 0.002 | ATM, RAD54L, TP53 |
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740) | - | 6.33 | 0.011 | CASP8, TP53, AKT1 |
CD4-positive, alpha-beta T cell activation (GO:0035710) | NEW | 6.4 | 0.025 | ATM, KRAS, ESR1, AKT1 |
positive regulation of monooxygenase activity (GO:0032770) | - | 6.47 | 0.004 | KRAS, ESR1, AKT1, CDH1 |
response to growth factor (GO:0070848) | NEW | 4.14 | 0.0 | ATM, PHB, KRAS, AKT1, CASP8, BARD1, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, HMMR |
response to antibiotic (GO:0046677) | - | 5.86 | 0.004 | RB1CC1, CASP8, ESR1, TP53, AKT1 |
positive regulation of intracellular signal transduction (GO:1902533) | - | 2.95 | 0.01 | ATM, PHB, KRAS, AKT1, CASP8, PPM1D, TP53, CDH1, RB1CC1, PIK3CA, ESR1, CHEK2, RAD51 |
epidermis development (GO:0008544) | NEW | 5.04 | 0.005 | ESR1, CASP8, TP53, AKT1, BRCA1, CHEK2, TSG101 |
fibroblast growth factor receptor signaling pathway (GO:0008543) | NEW | 5.3 | 0.038 | ESR1, TP53, CDH1, KRAS, AKT1, PIK3CA |
protein autophosphorylation (GO:0046777) | - | 4.46 | 0.007 | ATM, CDH1, TP53, AKT1, BRCA1, CHEK2, RAD51 |
nucleobase-containing compound metabolic process (GO:0006139) | - | 1.35 | 0.007 | ATM, NBN, XRCC3, BRCA2, AKT1, PALB2, BARD1, TP53, PHB, FAM175A, RB1CC1, KRAS, ESR1, CHEK2, BRCA1, BRIP1, RAD54L, RAD51 |
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625) | NEW | 6.09 | 0.012 | BRCA1, CASP8, TP53, AKT1 |
purine nucleoside metabolic process (GO:0042278) | NEW | 4.32 | 0.027 | PHB, ATM, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
regulation of protein modification by small protein conjugation or removal (GO:1903320) | NEW | 4.14 | 0.015 | KRAS, BRCA2, ESR1, TP53, PIK3CA, AKT1, BRCA1 |
positive regulation of protein modification by small protein conjugation or removal (GO:1903322) | NEW | 4.48 | 0.012 | ESR1, KRAS, TP53, AKT1, PIK3CA, BRCA1 |
negative regulation of lipid metabolic process (GO:0045833) | - | 5.33 | 0.001 | ESR1, CDH1, TP53, AKT1, PIK3CA, BRCA1 |
positive regulation of cellular protein metabolic process (GO:0032270) | - | 2.49 | 0.0 | ATM, NBN, KRAS, BRCA2, AKT1, CASP8, PPM1D, RAD51, TP53, PHB, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
cellular response to endogenous stimulus (GO:0071495) | - | 3.33 | 0.026 | ATM, KRAS, AKT1, CASP8, RAD51, TP53, CDH1, RB1CC1, PIK3CA, ESR1, CHEK2, RAD54L, HMMR, BRCA1, TSG101 |
phospholipid metabolic process (GO:0006644) | - | 3.88 | 0.025 | ATM, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1 |
cellular response to external stimulus (GO:0071496) | - | 4.2 | 0.001 | KRAS, ESR1, CASP8, TP53, CDH1, RB1CC1, PIK3CA, AKT1, BRCA1 |
regulation of protein localization to nucleus (GO:1900180) | - | 4.34 | 0.002 | KRAS, ESR1, TP53, CDH1, PIK3CA, AKT1, BRCA1, TSG101 |
DNA duplex unwinding (GO:0032508) | - | 5.37 | 0.043 | NBN, BRIP1, RAD51, TP53 |
cellular aromatic compound metabolic process (GO:0006725) | - | 1.3 | 0.014 | PHB, ATM, XRCC3, BRCA2, AKT1, PALB2, BARD1, TP53, FAM175A, RB1CC1, KRAS, ESR1, NBN, CHEK2, BRCA1, BRIP1, RAD54L, RAD51 |
positive regulation of stress-activated MAPK cascade (GO:0032874) | NEW | 4.82 | 0.002 | ATM, ESR1, CDH1, TP53, AKT1, PIK3CA |
mammary gland branching involved in thelarche (GO:0060744) | NEW | 8.12 | 0.002 | ESR1, TP53, AKT1 |
protein processing (GO:0016485) | NEW | 4.62 | 0.004 | KRAS, ESR1, CASP8, TP53, CDH1, PIK3CA, AKT1, TSG101 |
brain development (GO:0007420) | - | 4.24 | 0.017 | ATM, BRCA2, ESR1, BARD1, TP53, CDH1, AKT1, CHEK2 |
protein oligomerization (GO:0051259) | - | 3.71 | 0.012 | PHB, KRAS, CASP8, TP53, CDH1, RB1CC1, PIK3CA, AKT1, BRCA1, RAD51 |
cell cycle phase transition (GO:0044770) | - | 4.24 | 0.048 | ATM, ESR1, PPM1D, TP53, AKT1, BRCA1, CHEK2 |
cellular response to epidermal growth factor stimulus (GO:0071364) | NEW | 6.47 | 0.0 | TP53, BRCA1, ESR1, AKT1, CDH1 |
cellular response to growth factor stimulus (GO:0071363) | NEW | 4.27 | 0.0 | ATM, PHB, KRAS, AKT1, CASP8, BARD1, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, HMMR |
regulation of axonogenesis (GO:0050770) | NEW | 4.59 | 0.009 | KRAS, ESR1, CDH1, RB1CC1, TP53, AKT1, PIK3CA |
positive regulation of lymphocyte activation (GO:0051251) | - | 4.07 | 0.004 | ATM, KRAS, BRCA2, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1 |
cellular response to organic cyclic compound (GO:0071407) | - | 3.93 | 0.0 | ATM, KRAS, AKT1, CASP8, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
negative regulation of RNA metabolic process (GO:0051253) | - | 2.66 | 0.046 | ATM, PHB, KRAS, AKT1, CASP8, BARD1, TP53, CDH1, RAD51, ESR1, PIK3CA, BRCA1, CHEK2, TSG101 |
regulation of lymphocyte proliferation (GO:0050670) | NEW | 4.46 | 0.041 | ATM, KRAS, ESR1, CDH1, TP53, AKT1, PIK3CA |
positive regulation of lymphocyte proliferation (GO:0050671) | NEW | 4.85 | 0.003 | ATM, KRAS, ESR1, CDH1, TP53, AKT1, PIK3CA |
regulation of cytokine production (GO:0001817) | NEW | 3.4 | 0.023 | ATM, KRAS, AKT1, CASP8, TP53, CDH1, HMMR, ESR1, PIK3CA, BRCA1, TSG101 |
negative regulation of cell morphogenesis involved in differentiation (GO:0010771) | NEW | 4.96 | 0.047 | TP53, ESR1, AKT1, CDH1 |
glucose metabolic process (GO:0006006) | - | 4.94 | 0.048 | ESR1, CDH1, TP53, AKT1, PIK3CA, RAD51 |
regulation of response to stress (GO:0080134) | - | 2.53 | 0.0 | ATM, PHB, KRAS, AKT1, CASP8, CDH1, PPM1D, RAD51, TP53, FAM175A, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, HMMR |
negative regulation of cytokine production (GO:0001818) | NEW | 4.4 | 0.031 | ATM, KRAS, ESR1, CDH1, TP53, AKT1, PIK3CA |
regulation of cellular response to stress (GO:0080135) | - | 3.4 | 0.0 | ATM, PHB, AKT1, CASP8, CDH1, PPM1D, TP53, FAM175A, RB1CC1, PIK3CA, ESR1, BRCA1, RAD51 |
cellular response to lipopolysaccharide (GO:0071222) | NEW | 4.94 | 0.01 | ATM, ESR1, CDH1, TP53, AKT1, PIK3CA |
T cell activation (GO:0042110) | NEW | 4.45 | 0.0 | ATM, KRAS, BRCA2, AKT1, CASP8, TP53, CDH1, ESR1, BRCA1, CHEK2 |
cellular response to acid chemical (GO:0071229) | NEW | 4.67 | 0.026 | ATM, ESR1, CDH1, RB1CC1, TP53, AKT1, BRCA1 |
glycerolipid biosynthetic process (GO:0045017) | - | 4.53 | 0.0 | ATM, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1, TSG101 |
angiogenesis (GO:0001525) | NEW | 4.15 | 0.007 | ATM, KRAS, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, HMMR |
response to gamma radiation (GO:0010332) | - | 5.78 | 0.001 | ATM, CHEK2, BRCA2, TP53, AKT1 |
organic substance metabolic process (GO:0071704) | - | 0.63 | 0.02 | ATM, PALB2, TP53, FAM175A, RB1CC1, PIK3CA, XRCC3, RAD54L, PHB, CASP8, PPM1D, KRAS, BRCA1, NBN, BARD1, CDH1, AKT1, BRIP1, HMMR, BRCA2, RAD51, ESR1, CHEK2, TSG101 |
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028) | - | 5.94 | 0.038 | CASP8, TP53, AKT1 |
positive regulation of JAK-STAT cascade (GO:0046427) | NEW | 5.44 | 0.004 | TP53, ESR1, AKT1, PIK3CA, CDH1 |
DNA damage response, signal transduction by p53 class mediator (GO:0030330) | - | 5.3 | 0.0 | ATM, NBN, BRCA2, TP53, CDH1, ESR1, BRCA1 |
response to tumor necrosis factor (GO:0034612) | - | 4.93 | 0.002 | CASP8, TP53, CDH1, PIK3CA, AKT1, BRCA1, HMMR |
apoptotic process (GO:0006915) | - | 3.14 | 0.045 | ATM, PHB, KRAS, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
negative regulation of cell cycle (GO:0045786) | - | 3.67 | 0.046 | ATM, NBN, KRAS, AKT1, CASP8, BARD1, PPM1D, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
negative regulation of RNA biosynthetic process (GO:1902679) | - | 2.7 | 0.034 | ATM, PHB, KRAS, AKT1, CASP8, BARD1, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
regulation of nitrogen compound metabolic process (GO:0051171) | - | 1.36 | 0.02 | PHB, NBN, KRAS, BRCA2, AKT1, CDH1, BARD1, TP53, FAM175A, RB1CC1, RAD51, ESR1, PIK3CA, BRCA1, BRIP1, CHEK2, TSG101 |
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | - | 5.84 | 0.011 | ATM, AKT1, PIK3CA |
positive regulation of nitrogen compound metabolic process (GO:0051173) | - | 2.29 | 0.018 | PHB, BRCA2, ESR1, TP53, FAM175A, CDH1, AKT1, BRCA1, CHEK2, RAD51 |
ribonucleoside metabolic process (GO:0009119) | NEW | 4.21 | 0.038 | PHB, ATM, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
macromolecule catabolic process (GO:0009057) | - | 3.0 | 0.0 | ATM, XRCC3, KRAS, BRCA2, AKT1, CASP8, PPM1D, TSG101, TP53, CDH1, RAD51, PIK3CA, ESR1, CHEK2, RAD54L, BRCA1, HMMR |
DNA recombination (GO:0006310) | - | 4.39 | 0.0 | ATM, NBN, XRCC3, BRCA2, AKT1, PALB2, TP53, ESR1, CHEK2, RAD54L, BRCA1, RAD51 |
DNA damage checkpoint (GO:0000077) | - | 5.37 | 0.0 | ATM, NBN, PIK3CA, FAM175A, TP53, AKT1, BRCA1, BRIP1, CHEK2 |
cell cycle checkpoint (GO:0000075) | - | 4.79 | 0.0 | ATM, NBN, XRCC3, ESR1, TP53, FAM175A, PIK3CA, AKT1, BRCA1, BRIP1, CHEK2, RAD51 |
regulation of cell cycle (GO:0051726) | - | 2.93 | 0.0 | ATM, NBN, XRCC3, KRAS, BRCA2, AKT1, CASP8, PPM1D, BARD1, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
response to ketone (GO:1901654) | - | 4.53 | 0.003 | ATM, KRAS, ESR1, CDH1, TP53, AKT1, PIK3CA |
mitotic G2 DNA damage checkpoint (GO:0007095) | NEW | 7.24 | 0.036 | ATM, NBN, TP53 |
glycosyl compound catabolic process (GO:1901658) | NEW | 6.02 | 0.005 | ATM, PHB, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
mitotic cell cycle checkpoint (GO:0007093) | - | 5.31 | 0.0 | ATM, NBN, ESR1, TP53, PIK3CA, AKT1, BRCA1, RAD51 |
regulation of synaptic transmission (GO:0050804) | NEW | 4.09 | 0.046 | ATM, KRAS, ESR1, BARD1, TP53, CDH1, PIK3CA, AKT1 |
limb morphogenesis (GO:0035108) | NEW | 5.05 | 0.013 | ESR1, CDH1, TP53, AKT1, CHEK2, BRCA1 |
regulation of histone acetylation (GO:0035065) | NEW | 5.74 | 0.035 | BRCA1, ESR1, TP53, AKT1 |
positive regulation of histone acetylation (GO:0035066) | NEW | 6.33 | 0.001 | BRCA1, ESR1, TP53, AKT1 |
positive regulation of alpha-beta T cell activation (GO:0046635) | NEW | 5.76 | 0.009 | ATM, BRCA1, ESR1, TP53, AKT1 |
appendage morphogenesis (GO:0035107) | NEW | 5.05 | 0.013 | ESR1, CDH1, TP53, AKT1, CHEK2, BRCA1 |
alpha-beta T cell differentiation (GO:0046632) | NEW | 6.15 | 0.003 | TP53, BRCA1, KRAS, ESR1, AKT1 |
alpha-beta T cell activation (GO:0046631) | NEW | 5.92 | 0.0 | ATM, ESR1, KRAS, TP53, AKT1, BRCA1 |
male gonad development (GO:0008584) | NEW | 5.08 | 0.0 | ESR1, CASP8, TP53, CDH1, PIK3CA, AKT1, BRCA1, CHEK2 |
female gamete generation (GO:0007292) | NEW | 5.99 | 0.001 | CHEK2, BRCA2, TP53, AKT1, RAD51 |
membrane organization (GO:0061024) | - | 3.04 | 0.002 | ATM, PHB, KRAS, RAD51, TP53, CDH1, HMMR, AKT1, PIK3CA, BRCA1, CHEK2, TSG101 |
signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | - | 5.59 | 0.038 | ATM, CHEK2, ESR1, TP53 |
signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | - | 5.59 | 0.038 | ATM, CHEK2, ESR1, TP53 |
nucleobase-containing compound catabolic process (GO:0034655) | NEW | 3.9 | 0.0 | PHB, ATM, XRCC3, KRAS, BRCA2, AKT1, CASP8, PPM1D, TP53, CDH1, RAD51, ESR1, PIK3CA, RAD54L, BRIP1, CHEK2, TSG101 |
signal transduction by phosphorylation (GO:0023014) | - | 3.79 | 0.0 | ATM, KRAS, AKT1, CASP8, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1 |
positive regulation of cell cycle arrest (GO:0071158) | - | 5.29 | 0.0 | ATM, ESR1, CDH1, TP53, AKT1, BRCA1 |
signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | - | 5.59 | 0.038 | ATM, CHEK2, ESR1, TP53 |
positive regulation of macromolecule metabolic process (GO:0010604) | - | 1.81 | 0.0 | NBN, PHB, KRAS, BRCA2, AKT1, CASP8, CDH1, BARD1, PIK3CA, FAM175A, RB1CC1, TP53, ESR1, BRCA1, CHEK2, RAD51 |
response to bacterium (GO:0009617) | NEW | 4.18 | 0.003 | AKT1, CASP8, PPM1D, RAD51, TP53, PIK3CA, ESR1, HMMR |
peptidyl-amino acid modification (GO:0018193) | - | 2.98 | 0.0 | PHB, ATM, KRAS, BRCA2, AKT1, CASP8, TP53, CDH1, RAD51, ESR1, PIK3CA, BRCA1, CHEK2, TSG101 |
positive regulation of steroid biosynthetic process (GO:0010893) | NEW | 7.16 | 0.049 | ESR1, AKT1, CDH1 |
DNA replication (GO:0006260) | - | 4.51 | 0.001 | ATM, PHB, KRAS, PIK3CA, TP53, AKT1, BRCA1, RAD51 |
purine ribonucleoside triphosphate catabolic process (GO:0009207) | NEW | 9.73 | 0.002 | PHB, ATM, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
purine ribonucleoside triphosphate metabolic process (GO:0009205) | NEW | 4.81 | 0.006 | PHB, ATM, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
ribonucleoside triphosphate catabolic process (GO:0009203) | NEW | 9.73 | 0.002 | ATM, PHB, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
regulation of macromolecule metabolic process (GO:0060255) | - | 1.08 | 0.006 | ATM, NBN, KRAS, BRCA2, AKT1, CASP8, CDH1, BARD1, RAD51, TP53, PHB, FAM175A, RB1CC1, PIK3CA, ESR1, BRCA1, BRIP1, CHEK2, TSG101 |
cell differentiation involved in embryonic placenta development (GO:0060706) | - | 6.59 | 0.0 | TP53, CASP8, ESR1, AKT1, TSG101 |
lymphocyte activation (GO:0046649) | - | 3.96 | 0.004 | ATM, NBN, KRAS, ESR1, CASP8, TP53, CDH1, AKT1, BRCA1, CHEK2 |
regulation of neuron projection development (GO:0010975) | NEW | 3.69 | 0.006 | KRAS, ESR1, BARD1, PIK3CA, CDH1, RB1CC1, TP53, AKT1, BRCA1, CHEK2 |
intracellular steroid hormone receptor signaling pathway (GO:0030518) | - | 5.47 | 0.005 | PHB, BRCA1, ESR1, CHEK2, TP53 |
purine ribonucleoside metabolic process (GO:0046128) | NEW | 4.33 | 0.025 | ATM, PHB, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
platelet activation (GO:0030168) | - | 4.96 | 0.034 | KRAS, ESR1, CDH1, RB1CC1, TP53, AKT1, PIK3CA |
spermatogenesis (GO:0007283) | NEW | 3.7 | 0.003 | ATM, KRAS, BRCA2, AKT1, CASP8, RAD51, TP53, CDH1, PIK3CA, ESR1, TSG101 |
positive regulation of oxidoreductase activity (GO:0051353) | - | 5.94 | 0.028 | TP53, KRAS, ESR1, AKT1, CDH1 |
aromatic compound catabolic process (GO:0019439) | NEW | 3.79 | 0.0 | PHB, ATM, XRCC3, KRAS, BRCA2, AKT1, CASP8, PPM1D, TP53, CDH1, RAD51, ESR1, PIK3CA, CHEK2, RAD54L, BRIP1, BRCA1, TSG101 |
regulation of kidney development (GO:0090183) | NEW | 5.72 | 0.0 | ESR1, CDH1, TP53, AKT1, CHEK2, BRCA1 |
positive regulation of mononuclear cell proliferation (GO:0032946) | NEW | 4.84 | 0.003 | ATM, KRAS, ESR1, CDH1, TP53, AKT1, PIK3CA |
regulation of mononuclear cell proliferation (GO:0032944) | NEW | 4.45 | 0.043 | ATM, KRAS, ESR1, CDH1, TP53, AKT1, PIK3CA |
response to lipopolysaccharide (GO:0032496) | NEW | 4.03 | 0.018 | ATM, KRAS, ESR1, CASP8, TP53, CDH1, PIK3CA, AKT1 |
regulation of mitotic cell cycle (GO:0007346) | - | 3.71 | 0.0 | ATM, NBN, XRCC3, KRAS, BRCA2, AKT1, CASP8, PPM1D, BARD1, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, TSG101 |
regulation of protein secretion (GO:0050708) | NEW | 3.77 | 0.007 | ATM, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, HMMR |
cellular response to tumor necrosis factor (GO:0071356) | NEW | 5.19 | 0.009 | CDH1, TP53, AKT1, PIK3CA, BRCA1, HMMR |
regulation of cytokine secretion (GO:0050707) | NEW | 4.74 | 0.0 | ATM, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, HMMR |
gonad development (GO:0008406) | - | 4.92 | 0.0 | ATM, BRCA2, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2 |
cellular component organization (GO:0016043) | - | 1.24 | 0.005 | PHB, ATM, KRAS, BRCA2, AKT1, CASP8, CDH1, TP53, FAM175A, RB1CC1, RAD51, ESR1, NBN, CHEK2, RAD54L, BRCA1, TSG101 |
macromolecular complex assembly (GO:0065003) | - | 2.55 | 0.023 | PHB, ATM, KRAS, BRCA2, AKT1, CASP8, TP53, CDH1, RB1CC1, RAD51, ESR1, PIK3CA, BRCA1, CHEK2, TSG101 |
ribonucleotide catabolic process (GO:0009261) | NEW | 6.43 | 0.004 | PHB, ATM, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
ribonucleoside monophosphate catabolic process (GO:0009158) | NEW | 8.12 | 0.005 | PHB, ATM, BRCA2, XRCC3, TP53, ESR1, BRCA1, BRIP1, RAD51 |
purine ribonucleotide catabolic process (GO:0009154) | NEW | 6.47 | 0.004 | ATM, PHB, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
purine ribonucleotide metabolic process (GO:0009150) | NEW | 4.16 | 0.044 | ATM, PHB, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
regulation of cell cycle phase transition (GO:1901987) | - | 4.15 | 0.0 | ATM, NBN, BRCA2, AKT1, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
negative regulation of DNA replication (GO:0008156) | - | 6.17 | 0.0 | ATM, CHEK2, BRCA2, TP53, CDH1 |
positive regulation of protein acetylation (GO:1901985) | NEW | 6.15 | 0.004 | BRCA1, ESR1, TP53, AKT1 |
metabolic process (GO:0008152) | - | 0.58 | 0.033 | ATM, PALB2, TP53, FAM175A, RB1CC1, PIK3CA, XRCC3, RAD54L, PHB, CASP8, PPM1D, KRAS, BRCA1, NBN, BARD1, CDH1, AKT1, BRIP1, HMMR, BRCA2, NQO2, RAD51, ESR1, CHEK2, TSG101 |
heart development (GO:0007507) | - | 4.24 | 0.003 | ATM, ESR1, CASP8, CDH1, RB1CC1, TP53, AKT1, CHEK2 |
negative regulation of cell cycle phase transition (GO:1901988) | - | 4.74 | 0.0 | ATM, NBN, ESR1, TP53, CDH1, PIK3CA, AKT1, BRCA1, CHEK2, RAD51 |
regulation of phosphatidylinositol 3-kinase activity (GO:0043551) | NEW | 6.02 | 0.009 | TP53, ESR1, AKT1, PIK3CA |
regulation of lipid kinase activity (GO:0043550) | NEW | 5.84 | 0.029 | TP53, AKT1, ESR1, PIK3CA |
cellular response to nitrogen compound (GO:1901699) | - | 3.79 | 0.01 | ATM, KRAS, AKT1, CASP8, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, RAD51 |
positive regulation of protein catabolic process (GO:0045732) | - | 4.18 | 0.023 | ESR1, BARD1, CDH1, TP53, AKT1, PIK3CA |
positive regulation of myeloid cell differentiation (GO:0045639) | NEW | 5.33 | 0.0 | KRAS, ESR1, CASP8, CDH1, TP53, AKT1, BRCA1 |
response to fibroblast growth factor (GO:0071774) | NEW | 6.17 | 0.014 | KRAS, ESR1, CDH1, TP53, AKT1, PIK3CA, CHEK2 |
regulation of myeloid cell differentiation (GO:0045637) | NEW | 4.56 | 0.035 | KRAS, ESR1, CASP8, CDH1, TP53, AKT1, BRCA1 |
negative regulation of cell growth (GO:0030308) | - | 4.58 | 0.002 | PHB, KRAS, AKT1, TP53, TSG101, ESR1, BRCA1, HMMR |
dephosphorylation (GO:0016311) | NEW | 4.06 | 0.022 | ATM, CASP8, PPM1D, TP53, CDH1, AKT1, CHEK2, RAD51 |
tube formation (GO:0035148) | NEW | 4.98 | 0.002 | ESR1, CASP8, CDH1, TP53, AKT1, BRCA1, CHEK2 |
negative regulation of signaling (GO:0023057) | - | 2.65 | 0.045 | PHB, ESR1, CASP8, TP53, RB1CC1, CDH1, AKT1, BRCA1 |
purine nucleoside monophosphate catabolic process (GO:0009128) | NEW | 7.94 | 0.005 | PHB, ATM, BRCA2, XRCC3, TP53, ESR1, BRCA1, BRIP1, RAD51 |
positive regulation of nitric-oxide synthase activity (GO:0051000) | - | 6.78 | 0.029 | ESR1, KRAS, AKT1 |
negative regulation of cell communication (GO:0010648) | - | 2.66 | 0.046 | PHB, ESR1, CASP8, TP53, RB1CC1, CDH1, AKT1, BRCA1 |
axon guidance (GO:0007411) | NEW | 4.44 | 0.001 | ATM, KRAS, ESR1, TP53, CDH1, RB1CC1, PIK3CA, AKT1, BRCA1, CHEK2, RAD51 |
mitotic cell cycle phase transition (GO:0044772) | - | 4.27 | 0.046 | ATM, ESR1, PPM1D, TP53, AKT1, BRCA1, CHEK2 |
purine nucleoside monophosphate metabolic process (GO:0009126) | NEW | 4.69 | 0.003 | PHB, ATM, XRCC3, BRCA2, AKT1, TP53, ESR1, BRCA1, BRIP1, RAD51 |
nucleoside monophosphate catabolic process (GO:0009125) | NEW | 7.65 | 0.006 | PHB, ATM, BRCA2, XRCC3, TP53, ESR1, BRCA1, BRIP1, RAD51 |
telomere maintenance (GO:0000723) | - | 5.37 | 0.049 | ATM, NBN, TP53, XRCC3 |
recombinational repair (GO:0000725) | - | 5.37 | 0.0 | ATM, NBN, BRCA2, PALB2, XRCC3, BRCA1, RAD54L, RAD51 |
double-strand break repair via homologous recombination (GO:0000724) | - | 5.38 | 0.0 | ATM, NBN, BRCA2, PALB2, XRCC3, BRCA1, RAD54L, RAD51 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739) | - | 6.33 | 0.011 | CASP8, TP53, AKT1 |
primary metabolic process (GO:0044238) | - | 0.69 | 0.011 | ATM, PALB2, TP53, FAM175A, RB1CC1, PIK3CA, XRCC3, RAD54L, PHB, CASP8, PPM1D, KRAS, BRCA1, NBN, BARD1, CDH1, AKT1, BRIP1, HMMR, BRCA2, RAD51, ESR1, CHEK2, TSG101 |
positive regulation of cell differentiation (GO:0045597) | - | 3.01 | 0.002 | ATM, KRAS, BRCA2, AKT1, CASP8, BARD1, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
negative regulation of transcription, DNA-templated (GO:0045892) | - | 2.75 | 0.029 | ATM, PHB, KRAS, AKT1, CASP8, BARD1, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, TSG101 |
response to acid chemical (GO:0001101) | NEW | 4.05 | 0.03 | ATM, ESR1, TP53, CDH1, RB1CC1, PIK3CA, AKT1, BRCA1, RAD51 |
positive regulation of NF-kappaB transcription factor activity (GO:0051092) | NEW | 4.85 | 0.013 | ESR1, CASP8, TP53, CDH1, KRAS, AKT1 |
negative regulation of cellular protein metabolic process (GO:0032269) | - | 2.88 | 0.0 | ATM, KRAS, BRCA2, AKT1, CASP8, RAD51, TP53, CDH1, PIK3CA, ESR1, BRCA1, CHEK2, HMMR |
regulation of sequence-specific DNA binding transcription factor activity (GO:0051090) | - | 3.83 | 0.036 | ATM, PHB, KRAS, ESR1, CASP8, TP53, CDH1, PIK3CA, AKT1 |
aging (GO:0007568) | - | 4.16 | 0.0 | ATM, BRCA2, AKT1, CASP8, TP53, RB1CC1, CDH1, ESR1, BRCA1, CHEK2 |
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630) | - | 5.44 | 0.0 | ATM, BRCA2, CASP8, TP53, AKT1, BRCA1, CHEK2 |
positive regulation of developmental process (GO:0051094) | - | 2.77 | 0.027 | ATM, KRAS, BRCA2, AKT1, CASP8, BARD1, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
monosaccharide metabolic process (GO:0005996) | - | 4.57 | 0.003 | KRAS, ESR1, TP53, CDH1, TSG101, AKT1, PIK3CA, RAD51 |
macromolecule metabolic process (GO:0043170) | - | 0.83 | 0.001 | ATM, PALB2, TP53, FAM175A, RB1CC1, XRCC3, RAD54L, PHB, CASP8, PPM1D, PIK3CA, BRCA1, NBN, BARD1, CDH1, AKT1, BRIP1, HMMR, BRCA2, TSG101, ESR1, CHEK2, RAD51 |
positive regulation of proteolysis (GO:0045862) | - | 3.86 | 0.002 | ESR1, CASP8, CDH1, TP53, AKT1, PIK3CA |
glycerophospholipid metabolic process (GO:0006650) | - | 4.13 | 0.003 | ATM, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, BRCA1 |
positive regulation of histone H3-K9 acetylation (GO:2000617) | NEW | 7.65 | 0.024 | BRCA1, TP53 |
positive regulation of cellular metabolic process (GO:0031325) | - | 1.81 | 0.0 | PHB, NBN, KRAS, BRCA2, AKT1, CASP8, CDH1, TP53, FAM175A, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
mitotic cell cycle process (GO:1903047) | - | 3.12 | 0.0 | ATM, NBN, ESR1, PPM1D, BARD1, RAD51, TP53, CDH1, PIK3CA, AKT1, BRCA1, CHEK2, TSG101 |
nucleic acid metabolic process (GO:0090304) | - | 1.46 | 0.002 | ATM, NBN, BRCA2, XRCC3, PALB2, BARD1, TP53, PHB, FAM175A, RB1CC1, ESR1, AKT1, CHEK2, BRCA1, BRIP1, RAD54L, RAD51 |
negative regulation of cell cycle process (GO:0010948) | - | 4.37 | 0.0 | ATM, NBN, ESR1, TP53, CDH1, PIK3CA, AKT1, BRCA1, CHEK2, RAD51 |
positive regulation of cell death (GO:0010942) | - | 3.32 | 0.008 | ATM, PHB, KRAS, AKT1, CASP8, PPM1D, BARD1, TP53, CDH1, PIK3CA, ESR1 |
regulation of cell death (GO:0010941) | - | 2.43 | 0.0 | ATM, PHB, KRAS, AKT1, CASP8, PALB2, BARD1, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1 |
mitotic nuclear division (GO:0007067) | NEW | 4.05 | 0.004 | ATM, TP53, CDH1, RAD51, AKT1, BRCA1, CHEK2, TSG101 |
negative regulation of transcription by competitive promoter binding (GO:0010944) | NEW | 7.43 | 0.015 | PHB, TP53, CDH1 |
intracellular receptor signaling pathway (GO:0030522) | - | 4.6 | 0.001 | PHB, AKT1, CASP8, TP53, ESR1, BRCA1, CHEK2, TSG101 |
cellular response to organonitrogen compound (GO:0071417) | - | 3.87 | 0.029 | ATM, KRAS, BRCA2, AKT1, CASP8, TP53, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, RAD51 |
regulation of mesenchymal cell proliferation (GO:0010464) | NEW | 6.17 | 0.003 | TP53, CHEK2, ESR1, AKT1, CDH1 |
gene expression (GO:0010467) | NEW | 5.8 | 0.046 | ATM, PHB, KRAS, AKT1, RAD51, TP53, PIK3CA, ESR1, BRCA1, TSG101 |
purine nucleoside catabolic process (GO:0006152) | NEW | 7.16 | 0.003 | PHB, ATM, XRCC3, KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRIP1, RAD51 |
RNA catabolic process (GO:0006401) | NEW | 4.3 | 0.05 | ATM, CASP8, PPM1D, TP53, AKT1, RAD51 |
hematopoietic or lymphoid organ development (GO:0048534) | NEW | 4.49 | 0.0 | KRAS, BRCA2, ESR1, TP53, CDH1, PIK3CA, AKT1, BRCA1, CHEK2 |
positive regulation of T cell proliferation (GO:0042102) | NEW | 5.16 | 0.006 | ATM, CASP8, TP53, KRAS, CDH1, AKT1 |
stress-activated MAPK cascade (GO:0051403) | NEW | 5.45 | 0.001 | ATM, CASP8, KRAS, RB1CC1, TP53, AKT1 |
DNA damage response, signal transduction resulting in transcription (GO:0042772) | - | 7.02 | 0.0 | BRCA1, BRCA2, TP53, CDH1 |
signal transduction in response to DNA damage (GO:0042770) | - | 5.15 | 0.0 | ATM, NBN, BRCA2, BARD1, TP53, CDH1, ESR1, BRCA1, CHEK2 |
inner ear morphogenesis (GO:0042472) | NEW | 5.62 | 0.035 | TP53, BRCA1, ESR1, CHEK2, AKT1 |
odontogenesis of dentin-containing tooth (GO:0042475) | NEW | 5.52 | 0.002 | ATM, ESR1, CDH1, TP53, AKT1, CHEK2 |
stress-activated protein kinase signaling cascade (GO:0031098) | NEW | 5.41 | 0.001 | ATM, CASP8, KRAS, RB1CC1, TP53, AKT1 |
odontogenesis (GO:0042476) | NEW | 5.19 | 0.001 | ATM, ESR1, CDH1, RB1CC1, TP53, AKT1, CHEK2 |
replicative senescence (GO:0090399) | - | 7.24 | 0.001 | ATM, CHEK2, TP53, AKT1 |
regulation of leukocyte proliferation (GO:0070663) | NEW | 4.4 | 0.048 | ATM, KRAS, ESR1, CDH1, TP53, AKT1, PIK3CA |
organelle fission (GO:0048285) | - | 3.79 | 0.0 | ATM, NBN, BRCA2, BARD1, TP53, CDH1, RAD51, AKT1, CHEK2, BRCA1, RAD54L, TSG101 |
viral process (GO:0016032) | - | 3.15 | 0.037 | PHB, KRAS, AKT1, CASP8, RAD51, TP53, HMMR, ESR1, PIK3CA, BRCA1, TSG101 |
immune effector process (GO:0002252) | - | 3.58 | 0.029 | ATM, NBN, KRAS, AKT1, CASP8, TP53, CDH1, PIK3CA, ESR1, HMMR |
negative regulation of protein phosphorylation (GO:0001933) | - | 3.79 | 0.001 | ATM, KRAS, AKT1, CASP8, TP53, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |
regulation of protein phosphorylation (GO:0001932) | - | 2.57 | 0.001 | PHB, ATM, KRAS, NBN, AKT1, CASP8, PPM1D, TP53, CDH1, RB1CC1, RAD51, ESR1, PIK3CA, BRCA1, CHEK2, HMMR |
positive regulation of protein phosphorylation (GO:0001934) | - | 2.95 | 0.0 | ATM, NBN, KRAS, AKT1, CASP8, PPM1D, TP53, PHB, CDH1, RB1CC1, PIK3CA, ESR1, BRCA1, CHEK2, RAD51 |